| 1 |
34871120 | Reduced calcineurin inhibitor exposure with antibody induction and recurrent hepatocellular carcinoma after liver transplantation. | 2022 Mar |
1 |
| 2 |
35143096 | The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations. | 2022 Feb 10 |
2 |
| 3 |
33887727 | Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant Recipients Maintained on Tacrolimus: A Systematic Review and Meta-Analysis. | 2021 |
1 |
| 4 |
34335631 | CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs. | 2021 |
1 |
| 5 |
32170593 | Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis. | 2020 Apr |
1 |
| 6 |
28257599 | Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis. | 2017 Jul |
1 |
| 7 |
25979971 | Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. | 2015 Jun 5 |
1 |
| 8 |
25142246 | Tacrolimus pharmacodynamics and pharmacogenetics along the calcineurin pathway in human lymphocytes. | 2014 Oct |
1 |
| 9 |
22863028 | Review article: use of induction therapy in liver transplantation. | 2012 Oct |
2 |
| 10 |
20484893 | Different immunosuppressive combinations on T-cell regulation in renal transplant recipients. | 2010 |
1 |
| 11 |
20528886 | The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins. | 2010 Aug |
2 |
| 12 |
20671192 | FK506 causes cellular and functional defects in human natural killer cells. | 2010 Dec |
1 |
| 13 |
19398001 | Clinical rejection and persistent immune regulation in kidney transplant patients. | 2009 Jul |
1 |
| 14 |
17889153 | Do anti-CD25 monoclonal antibodies potentiate posttransplant diabetes mellitus? | 2007 Sep |
1 |
| 15 |
16773453 | The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis. | 2006 Jul |
1 |
| 16 |
15866630 | Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age. | 2005 Apr |
1 |
| 17 |
16054825 | Tacrolimus versus cyclosporine induction therapy in pulmonary transplantation in miniature swine. | 2005 Sep |
1 |
| 18 |
16267794 | [Kidney transplantation in children]. | 2005 Jul-Aug |
1 |
| 19 |
16400900 | Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells. | 2005 Dec |
1 |
| 20 |
12773967 | New monoclonal antibodies in renal transplantation. | 2003 Mar |
1 |
| 21 |
12780674 | The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients. | 2003 Jun |
3 |
| 22 |
12372041 | Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation. | 2002 |
1 |
| 23 |
11174203 | Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). | 2001 Feb |
2 |
| 24 |
11053632 | Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses. | 2000 Sep |
1 |
| 25 |
8557519 | Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. | 1995 Sep |
4 |
| 26 |
8137548 | Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. | 1994 Mar |
1 |
| 27 |
7678231 | Inhibition of activation-induced changes in the structure of the T cell interleukin-7 receptor by cyclosporin A and FK506. | 1993 Jan |
1 |
| 28 |
1281674 | FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA. | 1992 Oct |
1 |
| 29 |
1690915 | The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis. | 1990 Mar |
2 |